Literature DB >> 7428793

Comparison of the effects of propranolol and labetalol on renal haemodynamics at rest and during exercise in essential hypertension.

J S Larsen, E B Pedersen.   

Abstract

The effect of exercise on renal haemodynamics was examined in young patients with mild essential hypertension. Four groups of subjects were studied: 13 normotensive, healthy control subjects, and 15 untreated, 11 propranolol-treated, and 6 labetalol-treated patients. Renal plasma flow (RPF) and glomerular filtration rate (GFR) were measured during four consecutive periods, a pre-exercise control period, two exercise periods with loads of 450 kpm/min and 600 kpm/min, respectively, and a post-exercise control period. In the untreated patients RPF and GFR were lower during exercise than in the normotensive control subjects, whereas no significant differences were found at rest. In the propranolol-treated patients the reduction in RPF and GFR during exercise was more pronounced than in the untreated hypertensives. In the labetalol-treated patients however, RPF and GFR were reduced only to the same degree as in the untreated hypertensives. The reduced renal blood flow in propranolol-treated patients may be attributed to a compensatory increase in sympathetic activity caused by an impaired cardiac response to exercise. The lack of reduction in renal blood flow during labetalol therapy could partly be related to alpha-adrenergic blockade in the renal vascular bed induced by labetalol, and partly to the smaller reduction in cardiac output during labetalol than during propranolol therapy.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7428793     DOI: 10.1007/bf00561580

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  15 in total

1.  Changes in glomerular filtration rate during long-term treatment with propranolol in patients with arterial hypertension.

Authors:  H Ibsen; P Sederberg-Olsen
Journal:  Clin Sci       Date:  1973-02       Impact factor: 6.124

2.  Glomerular filtration rate, renal plasma flow and filtration fraction in living donors before and after nephrectomy.

Authors:  P E Skov; H E Hansen
Journal:  Acta Med Scand       Date:  1974 Jan-Feb

Review 3.  Some aspects of kidney function, the renin-aldosterone system and sympathetic activity in essential hypertension.

Authors:  E B Pedersen
Journal:  Acta Med Scand Suppl       Date:  1980

4.  Glucagon and plasma catecholamines during beta-receptor blockade in exercising man.

Authors:  H Galbo; J J Holst; N J Christensen; J Hilsted
Journal:  J Appl Physiol       Date:  1976-06       Impact factor: 3.531

5.  Haemodynamic effects and plasma concentrations of labetalol during long-term treatment of essential hypertension.

Authors:  P Lund-Johansen; O M Bakke
Journal:  Br J Clin Pharmacol       Date:  1979-02       Impact factor: 4.335

6.  Acute and long-term effects of labetalol on systemic and pulmonary haemodynamics in hypertensive patients.

Authors:  T L Svendsen; S Rasmussen; O J Hartling; P E Nielsen; J Trap-Jensen
Journal:  Eur J Clin Pharmacol       Date:  1980-01       Impact factor: 2.953

7.  Haemodynamic effects of long-term oral labetalol.

Authors:  R C Edwards; E B Raftery
Journal:  Br J Clin Pharmacol       Date:  1976-08       Impact factor: 4.335

8.  Experience with labetalol in hypertension.

Authors:  P Bolli; J Waal-Manning; A J Wood; F O Simpson
Journal:  Br J Clin Pharmacol       Date:  1976-08       Impact factor: 4.335

9.  Acute haemodynamic effects of labetalol and its subsequent use of an oral hypotensive agent.

Authors:  A M Joekes; F D Thompson
Journal:  Br J Clin Pharmacol       Date:  1976-08       Impact factor: 4.335

10.  Effect of sodium loading and exercise on renal haemodynamics and urinary sodium excretion in young patients with essential hypertension before and during propranolol treatment.

Authors:  E B Pedersen
Journal:  Acta Med Scand       Date:  1977
View more
  8 in total

1.  Effects of dilevalol, an R, R-isomer of labetalol, on blood pressure and renal function in patients with mild-to-moderate essential hypertension.

Authors:  T Baba; S Murabayashi; K Aoyagi; T Ishizaki
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

Review 2.  Beta-blockers and renal function.

Authors:  R Wilkinson
Journal:  Drugs       Date:  1982-03       Impact factor: 9.546

3.  Intrinsic sympathomimetic activity of cardioselective beta-adrenoceptor blockers and effects on renal function.

Authors:  I G Mackay; A M Macnicol; H J Smith; A D Cumming; M L Watson
Journal:  Br J Clin Pharmacol       Date:  1985-09       Impact factor: 4.335

4.  The effects of selective beta-adrenoceptor antagonists and partial agonist activity on renal function during exercise in normal subjects and those with moderate renal impairment.

Authors:  D Taverner; I G Mackay; K Craig; M L Watson
Journal:  Br J Clin Pharmacol       Date:  1991-09       Impact factor: 4.335

5.  Comparison of the renal effects of dilevalol and carteolol in patients with mild to moderate essential hypertension.

Authors:  T Baba; S Murabayashi; T Tomiyama; K Takebe
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

Review 6.  Labetalol. A reappraisal of its pharmacology, pharmacokinetics and therapeutic use in hypertension and ischaemic heart disease.

Authors:  K L Goa; P Benfield; E M Sorkin
Journal:  Drugs       Date:  1989-05       Impact factor: 9.546

Review 7.  Clinical pharmacokinetics and kinetic-dynamic relationships of dilevalol and labetalol.

Authors:  R Donnelly; G J Macphee
Journal:  Clin Pharmacokinet       Date:  1991-08       Impact factor: 6.447

Review 8.  Combined alpha- and beta-receptor inhibition in the treatment of hypertension.

Authors:  B N Prichard
Journal:  Drugs       Date:  1984       Impact factor: 9.546

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.